Technical Analysis for LNTH - Lantheus Holdings, Inc.

Grade Last Price % Change Price Change
grade D 14.61 0.59% 0.09
LNTH closed up 0.59 percent on Friday, June 5, 2020, on 80 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical LNTH trend table...

Date Alert Name Type % Chg
Weak + Overbought Other 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
180 Bullish Setup Bullish Swing Setup 0.59%
Slingshot Bullish Bullish Swing Setup 0.59%
Weak + Overbought Other 0.59%
Outside Day Range Expansion 0.59%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Lantheus Holdings, Inc. is engaged in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The Company's medical imaging agents are used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. The Company's products include contrast agents and medical radiopharmaceuticals, including technetium generators. The Company's products include DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, Neurolite, Thallium Tl 201, Gallium Ga 67, Gludef, Quadramet and Ablavar. The Company is also engaged in developing agents, such as Flurpiridaz F 18, which is a myocardial perfusion imaging agent; 18F LMI 1195, which is a cardiac neuronal imaging agent, and LMI 1174, which is a vascular remodeling imaging agent.
Medicine Chemistry Diseases Chemical Elements Medical Imaging Medical Physics Coronary Artery Disease Peripheral Vascular Disease Stroke Medicinal Radiochemistry Radiopharmaceuticals Congestive Heart Failure Cardiovascular And Other Diseases F 18

Is LNTH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 29.8
52 Week Low 8.67
Average Volume 357,633
200-Day Moving Average 17.73
50-Day Moving Average 12.89
20-Day Moving Average 13.07
10-Day Moving Average 13.86
Average True Range 0.79
ADX 16.5
+DI 31.06
-DI 17.30
Chandelier Exit (Long, 3 ATRs ) 12.91
Chandelier Exit (Short, 3 ATRs ) 13.34
Upper Bollinger Band 14.99
Lower Bollinger Band 11.15
Percent B (%b) 0.9
BandWidth 29.41
MACD Line 0.44
MACD Signal Line 0.23
MACD Histogram 0.2135
Fundamentals Value
Market Cap 545.68 Million
Num Shares 37.3 Million
EPS 0.73
Price-to-Earnings (P/E) Ratio 20.01
Price-to-Sales 2.17
Price-to-Book 0.00
PEG Ratio 0.69
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.71
Resistance 3 (R3) 15.81 15.55 15.52
Resistance 2 (R2) 15.55 15.27 15.50 15.46
Resistance 1 (R1) 15.08 15.10 14.95 14.98 15.40
Pivot Point 14.82 14.82 14.76 14.77 14.82
Support 1 (S1) 14.35 14.54 14.22 14.25 13.82
Support 2 (S2) 14.09 14.37 14.04 13.76
Support 3 (S3) 13.62 14.09 13.70
Support 4 (S4) 13.52